[Stem cell therapy in ischemic heart disease]

Axel Cosmus Pyndt Diederichsen1, Jacob Eifer Møller, Malthe A M Kristiansen

  • 1Odense Universitetshospital, Center for Stamcellebehandling, Kardiologisk Afdeling B, Odense C. a.diederichsen@dadlnet.dk

Ugeskrift for Laeger
|March 21, 2006
PubMed

Insights

Stem cell therapy shows promise for heart repair, improving cardiac function in ischemic heart disease patients. Further research is needed to confirm safety and effectiveness for widespread clinical use.

Area of Science:

  • Regenerative Medicine
  • Cardiology
  • Stem Cell Biology

Context:

  • The heart possesses inherent regenerative capabilities.
  • Stem cell therapy is an emerging treatment modality in cardiovascular medicine.
  • Ischemic heart diseases remain a leading cause of mortality worldwide.

Purpose:

  • To evaluate the efficacy and safety of stem cell transplantation in patients with chronic or acute ischemic heart diseases.
  • To explore the potential of stem cells for myocardial regeneration and functional improvement.

Summary:

  • Clinical studies involving intracoronary or intracardiac transplantation of bone marrow stem cells have demonstrated positive outcomes in patients with ischemic heart conditions.
  • Treatment improved left ventricular function and regional myocardial perfusion.
  • No significant complications were reported in the observed studies.

Impact:

  • Stem cell therapy offers a potential new therapeutic strategy for managing ischemic heart disease.
  • Evidence suggests improved cardiac function, but further research on long-term morbidity and mortality is crucial before clinical implementation.

Related Concept Videos